EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pre-eclampsia with inflammatory and pro-resolving mediator fluctuations - contributions from hemolytic protozoan parasites

Kevin Roe

Vascular Pharmacology · 2025

DOI: 10.1016/j.vph.2025.107552 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vascular Pharmacology, 2025. Verfasst von Kevin Roe. Beteiligte Einrichtung: Retired, United States Patent and Trademark Office, 4975 Moorpark Ave, San Jose, California 95129, United States of America. Electronic address: kevi…. Hauptthemen laut MEDLINE: Pre-Eclampsia, Inflammation Mediators, Inflammation, Protozoan Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 89 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pre-eclampsia (PE) and eclampsia are inflammatory hypertension diseases which have globally caused countless millions of fatalities among pregnant women, and their pathogenesis has been a centuries-long mystery. Substantial experimental evidence, including extensive cytokine signatures, symptoms, characteristics and drug interactions, suggest initiation by hemolytic protozoan parasite infections which provide heme and iron for reactivation of iron-deprived bacterial and/or viral infections. However, there are unexplained PE and eclampsia secondary characteristics: (1) Why are endothelial dysfunction and vascular inflammation ubiquitous in pregnancies complicated by PE and eclampsia? (2) Why does pregnancy termination resolve the inflammation of pregnancies complicated by PE and eclampsia? (3) Why do omega-3 polyunsaturated fatty acids, including DHA and EFA and their derived resolvins, have decreased blood levels, whereas omega-6 polyunsaturated fatty acids have elevated levels? (4) Why is low-dose aspirin therapy frequently effective in preventing PE and eclampsia? There are now plausible explanations for these secondary characteristics. These explanations also support the hypothesis that PE and eclampsia are diseases induced by bacterial or viral infections concurrent with an almost asymptomatic strain of hemolytic protozoan parasite infection providing a virulence boost, with the reactivated infections inducing chronic inflammation. This also causes abnormal fluctuations in special pro-resolving mediators, including lipoxins, resolvins, protectins and maresins, which would normally participate in resolving acute inflammations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaInflammation MediatorsInflammationProtozoan InfectionsHemolysisPregnancy Complications, ParasiticHumansPregnancyFemaleAnimals

Stichwörter der Autor:innen

Bacterial infectionsHypertensionInflammationProtozoan infectionsSpecial pro-resolving mediatorsViral infections

Substanzen

Inflammation Mediators

Autor:innen und Institutionen

  • Retired, United States Patent and Trademark Office, 4975 Moorpark Ave, San Jose, California 95129, United States of America. Electronic address: kevin.roe@att.net.

Zitieren

APA

Roe, K. (2025). Pre-eclampsia with inflammatory and pro-resolving mediator fluctuations - contributions from hemolytic protozoan parasites. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2025.107552

Vancouver

Roe K. Pre-eclampsia with inflammatory and pro-resolving mediator fluctuations - contributions from hemolytic protozoan parasites. Vascular Pharmacology. 2025. doi:10.1016/j.vph.2025.107552

BibTeX
@article{Roe2025,
  author = {Roe, Kevin},
  title = {Pre-eclampsia with inflammatory and pro-resolving mediator fluctuations - contributions from hemolytic protozoan parasites},
  journal = {Vascular Pharmacology},
  year = {2025},
  doi = {10.1016/j.vph.2025.107552}
}
Kostenlos starten →